INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-10.31 | ₹-7.99 | ₹10.68 | ₹15.44 | ₹16.80 |
What is the latest Earnings Per Share (EPS) of INDOCO REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹-10.31 |
| Mar2025 | ₹-7.99 |
| Mar2024 | ₹10.68 |
| Mar2023 | ₹15.44 |
| Mar2022 | ₹16.80 |
How is Earnings Per Share (EPS) of INDOCO REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹-10.31 | Negative | |
| Mar2025 | ₹-7.99 | Negative | |
| Mar2024 | ₹10.68 | -30.83 | |
| Mar2023 | ₹15.44 | -8.10 | |
| Mar2022 | ₹16.80 | - | |
Compare Earnings Per Share (EPS) of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,236.4 Cr | 7.3% | 7.6% | -14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 7.3% |
7.6% |
-14.2% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses